Carisma Therapeutics Inc. Cash Flow Quality Index
Carisma Therapeutics Inc. cash flow quality index. Carisma Therapeutics Inc. (CARM) has a Cash Flow Quality Index of 0.04x as of September 2025. Operating cash flow of $1.91 Million is below net income of $44.72 Million, suggesting accrual-heavy earnings not yet converted to cash. See CARM FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Carisma Therapeutics Inc. (2016–2016)
Cash flow quality index of Carisma Therapeutics Inc. from 2016 to 2016. Historical Cash Flow Quality Index for Carisma Therapeutics Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CARM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Carisma Therapeutics Inc. Cash Flow Quality Index by Year (2016–2016)
Carisma Therapeutics Inc. cash flow quality index by year from 2016 to 2016. Year-by-year earnings quality comparison for Carisma Therapeutics Inc.. For the full cash flow conversion analysis, see Carisma Therapeutics Inc. cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.39x | $2.62 Million | $1.89 Million | — |